Immunai collected a hefty $215 million series B round back in 2021 after raising $60 million through a series A earlier that same year. Those funds have helped the company stretch its reach from ...

Google stock has gained over 34% in 2025 and trades near its all-time high as more investors view the company as an AI winner ...

Eli Lilly said Friday a combination using Verzenio reduced the risk of death by nearly 16% over two years for breast cancer ...

Spyre Therapeutics, Inc. ('Spyre” or the 'Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic ...

The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains.

“This latest study adds to the growing body of peer-reviewed evidence confirming that Cylinder’s model delivers not only better digestive health but also better access and equity,” said Bill Snyder, ...

What if your gut could hold the key to curing chronic disease? India’s premier science body, the Council of Scientific and ...

As we enter the final quarter of 2025, the fixed income landscape is shaped by slowing economic growth and the Federal ...

Check out the Nebraska high school cross country district results for Classes A and C. [email protected], ...

Fifth Third Bancorp ( NASDAQ: FITB) Q3 2025 Earnings Call October 17, 2025 9:00 AM EDT Thank you for standing by, and welcome to the Fifth Third Bancorp's Third Quarter 2025 Earnings Conference Call. ...

Prologis on Wednesday reported quarterly profit above Wall Street expectations and lifted its full-year outlook, helped by a surge in leasing activity and growing investments in data centers.